The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
The competing risk approach for prediction of preeclampsia
Abstract
The established method of assessing the risk for development of preeclampsia (PE) is to identify risk factors from maternal demographic characteristics and medical history; in the presence of such factors the patient is classified as high-risk and in their absence as low-risk. Although this approach is simple to perform, it has poor performance of predicting PE and does not provide patient-specific risks. This review describes a new approach which allows estimation of patient-specific risks of delivery with PE before any specified gestational age by maternal demographic characteristics and medical history with biomarkers obtained either individually or in combination at any stage in pregnancy. In the competing risks approach every woman has a personalized distribution of gestational age at delivery with PE and whether she develops PE or not before a specified gestational age depends on competition between delivery before or after development of PE. The personalized distribution comes from the application of Bayes theorem to combine a prior distribution, determined from maternal factors, with likelihoods from biomarkers. As new data become available, what were posterior probabilities take the role as the prior and data collected at different stages are combined by repeating the application of Bayes theorem to form a new posterior at each stage allowing for dynamic prediction of PE. The competing risk model can be used for precision medicine and risk stratification at different stages of pregnancy. In the first-trimester, the model has been applied to identify a high-risk group that would benefit from preventative therapeutic interventions. In the second-trimester, the model has been used to stratify the population into high- intermediate- and low-risk groups in need of different intensities of subsequent monitoring thereby minimizing unexpected adverse perinatal events. The competing risks model can also be used in surveillance of women presenting to specialist clinics with signs or symptoms of hypertensive disorders; combination of maternal factors and biomarkers provide patient-specific risks for PE leading to personalized stratification of the intensity of monitoring with risks updated on each visit on the basis of biomarker measurements.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Maynard, S. E., Min, J.-Y., Merchan, J., Lim, K.-H., Li, J., Mondal, S., Libermann, T. A., Morgan, J. P., Sellke, F. W., Stillman, I. E., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17189 · Cited by 4,101
Circulating angiogenic factors and the risk of preeclampsia
Levine, R. J., Maynard, S. E., Qian, C., Lim, K.-H., England, L. J., Yu, K. F., Schisterman, E. F., Thadhani, R., Sachs, B. P., Epstein, F. H., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031884 · Cited by 3,720
The Statistical Analysis of Failure Time Data
Kalbfleisch, J. D., & Prentice, R. L. (2002) · Wiley Series in Probability and Statistics · doi:10.1002/9781118032985 · Cited by 3,219
Circulating angiogenic factors and the risk of preeclampsia*
(2004) · Obstetrics & Gynecology · doi:10.1097/00006250-200405000-00028 · Cited by 2,615
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia
Rolnik, D. L., Wright, D., Poon, L. C., O’Gorman, N., Syngelaki, A., de Paco Matallana, C., Akolekar, R., Cicero, S., Janga, D., Singh, M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1704559 · Cited by 2,287
Self-citationThe Statistical Analysis of Failure Time Data
Klein, J. P. (1982) · Technometrics · doi:10.1080/00401706.1982.10487769 · Cited by 2,215
Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia
Zeisler, H., Llurba, E., Chantraine, F., Vatish, M., Staff, A. C., Sennström, M., Olovsson, M., Brennecke, S. P., Stepan, H., Allegranza, D., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1414838 · Cited by 1,783
The Statistical Analysis of Failure Time Data
Borgan, Ø. (2003) · Journal of the American Statistical Association · doi:10.1198/jasa.2003.s310 · Cited by 799
Koopmans, C. M., Bijlenga, D., Groen, H., Vijgen, S. M., Aarnoudse, J. G., Bekedam, D. J., van den Berg, P. P., de Boer, K., Burggraaff, J. M., Bloemenkamp, K. W., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60736-4 · Cited by 794
O’Gorman, N., Wright, D., Syngelaki, A., Akolekar, R., Wright, A., Poon, L. C., & Nicolaides, K. H. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.08.034 · Cited by 629
Self-citationAspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis
Roberge, S., Bujold, E., & Nicolaides, K. H. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.11.561 · Cited by 628
Self-citationCompeting Risks Model in Early Screening for Preeclampsia by Biophysical and Biochemical Markers
Akolekar, R., Syngelaki, A., Poon, L., Wright, D., & Nicolaides, K. H. (2013) · Fetal Diagnosis and Therapy · doi:10.1159/000341264 · Cited by 601
Self-citationWald, N. J., Cuckle, H. S., Brock, J. H., Peto, R., Polani, P. E., & Woodford, F. P. (1977) · PubMed · Cited by 527
Chappell, L. C., Duckworth, S., Seed, P. T., Griffin, M., Myers, J., Mackillop, L., Simpson, N., Waugh, J., Anumba, D., Kenny, L. C., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.003215 · Cited by 496
Verlohren, S., Herraiz, I., Lapaire, O., Schlembach, D., Moertl, M., Zeisler, H., Calda, P., Holzgreve, W., Galindo, A., Engels, T., et al. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2011.07.037 · Cited by 448
Akolekar, R., Syngelaki, A., Sarquis, R., Zvanca, M., & Nicolaides, K. H. (2011) · Prenatal Diagnosis · doi:10.1002/pd.2660 · Cited by 444
Self-citationScreening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks’ gestation
Tan, M. Y., Syngelaki, A., Poon, L. C., Rolnik, D. L., O'Gorman, N., Delgado, J. L., Akolekar, R., Konstantinidou, L., Tsavdaridou, M., Galeva, S., et al. (2018) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.19112 · Cited by 438
Self-citationUterine artery Doppler at 11 + 0 to 13 + 6 weeks in the prediction of pre‐eclampsia
Plasencia, W., Maiz, N., Bonino, S., Kaihura, C., & Nicolaides, K. H. (2007) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.5157 · Cited by 425 · cited 1×
“These models use maternal characteristics and medical history alone or in combination with biomarkers to quantify the individual patient-specific risk for PE, rather than just classifying women into high- and low-risk groups.(8-16) However, they do not allow the flexibility of selecting different gestational age cut-o…”
MethodSelf-citationCompeting risks model in screening for preeclampsia by maternal characteristics and medical history
Wright, D., Syngelaki, A., Akolekar, R., Poon, L. C., & Nicolaides, K. H. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.02.018 · Cited by 417
Self-citationTan, M. Y., Wright, D., Syngelaki, A., Akolekar, R., Cicero, S., Janga, D., Singh, M., Greco, E., Wright, A., Maclagan, K., et al. (2018) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.19039 · Cited by 385
Self-citationMaternal risk factors for hypertensive disorders in pregnancy: a multivariate approach
Poon, L. C. Y., Kametas, N. A., Chelemen, T., Leal, A., & Nicolaides, K. H. (2010) · Journal of Human Hypertension · doi:10.1038/jhh.2009.45 · Cited by 330
Self-citationAkolekar, R., Zaragoza, E., Poon, L. C. Y., Pepes, S., & Nicolaides, K. H. (2008) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.6244 · Cited by 265
Self-citationO'Gorman, N., Wright, D., Poon, L. C., Rolnik, D. L., Syngelaki, A., Wright, A., Akolekar, R., Cicero, S., Janga, D., Jani, J., et al. (2017) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.17399 · Cited by 259
Self-citationFirst‐trimester maternal serum pregnancy‐associated plasma protein‐A and pre‐eclampsia
Poon, L. C. Y., Maiz, N., Valencia, C., Plasencia, W., & Nicolaides, K. H. (2009) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.6280 · Cited by 237
Self-citationA Competing Risks Model in Early Screening for Preeclampsia
Wright, D., Akolekar, R., Syngelaki, A., Poon, L. C. Y., & Nicolaides, K. H. (2012) · Fetal Diagnosis and Therapy · doi:10.1159/000338470 · Cited by 235
Self-citationGallo, D. M., Wright, D., Casanova, C., Campanero, M., & Nicolaides, K. H. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.11.016 · Cited by 216
Self-citationPredictive performance of the competing risk model in screening for preeclampsia
Wright, D., Tan, M. Y., O’Gorman, N., Poon, L. C., Syngelaki, A., Wright, A., & Nicolaides, K. H. (2019) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.11.1087 · Cited by 207
Self-citationHypertensive disorders in pregnancy: screening by biophysical and biochemical markers at 11–13 weeks
Poon, L. C. Y., Akolekar, R., Lachmann, R., Beta, J., & Nicolaides, K. H. (2010) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.7628 · Cited by 175
Self-citationTsiakkas, A., Duvdevani, N., Wright, A., Wright, D. E., & Nicolaides, K. H. (2015) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.14811 · Cited by 173
Self-citationModel‐based screening by risk with application to down's syndrome
Royston, P., & Thompson, S. G. (1992) · Statistics in Medicine · doi:10.1002/sim.4780110211 · Cited by 173
Performance of a first-trimester screening of preeclampsia in a routine care low-risk setting
Scazzocchio, E., Figueras, F., Crispi, F., Meler, E., Masoller, N., Mula, R., & Gratacos, E. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.12.016 · Cited by 160
Chaiworapongsa, T., Romero, R. J., Korzeniewski, S. J., Kusanovic, J. P., Soto, E., Lam, J., Dong, Z., Than, N. G., Yeo, L., Hernandez‐Andrade, E. A., et al. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.01.016 · Cited by 153
Hidden high rate of pre‐eclampsia in twin compared with singleton pregnancy
Francisco, C., Wright, D. E., Benkő, Z., Syngelaki, A., & Nicolaides, K. H. (2017) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.17470 · Cited by 152
Self-citationChaiworapongsa, T., Romero, R. J., Savasan, Z. A., Kusanovic, J. P., Oggè, G., Soto, E., Dong, Z., Tarca, A. L., Bhatti, G., & Hassan, S. S. (2011) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2011.589932 · Cited by 147
Wright, D. E., Rolnik, D. L., Syngelaki, A., Matallana, C. D. P., Machuca, M., de Alvarado, M., Mastrodima, S., Tan, M. Y., Shearing, S., Persico, N., et al. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.02.014 · Cited by 134
Self-citationCrovetto, F., Figueras, F., Triunfo, S., Crispi, F., Rodríguez‐Sureda, V., Domı́nguez, C., Llurba, E., & Gratacós, E. (2014) · Prenatal Diagnosis · doi:10.1002/pd.4519 · Cited by 130
Tayyar, A., Guerra, L., Wright, A., Wright, D. E., & Nicolaides, K. H. (2015) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.14789 · Cited by 128
Self-citationAndrietti, S., Silva, M. D. L., Wright, A., Wright, D. E., & Nicolaides, K. H. (2015) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.15812 · Cited by 120
Self-citationAspirin for the Prevention of Preterm and Term Preeclampsia: Systematic Review and Meta-Analysis
Roberge, S., Bujold, E., & Nicolaides, K. H. (2018) · Obstetric Anesthesia Digest · doi:10.1097/01.aoa.0000547277.94540.23 · Cited by 120
Self-citationTsiakkas, A., Saiid, Y., Wright, A., Wright, D., & Nicolaides, K. H. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.02.016 · Cited by 119 · cited 2×
“Those found to be useful at 11-13 and 19-24 weeks’ gestation are MAP, UtA-PI and PLGF, in the early third trimester MAP, UtAPI, PLGF and serum soluble fms-like tyrosine kinase-1 (sFLT-1) and in late third trimester MAP, PLGF and sFLT-1.(19,26-32)”
BackgroundMethodWright, A., Wright, D. E., Ispas, C. A., Poon, L. C., & Nicolaides, K. H. (2015) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.14783 · Cited by 111
Self-citationScreening for pre‐eclampsia at 35–37 weeks' gestation
Panaitescu, A. M., Ciobanu, A.-M., Syngelaki, A., Wright, A., Wright, D. E., & Nicolaides, K. H. (2018) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.19111 · Cited by 96
Self-citationBenton, S. J., Hu, Y., Xie, F., Kupfer, K., Lee, S., Magee, L. A., & von Dadelszen, P. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2011.06.058 · Cited by 90
Prediction of preeclampsia utilizing the first trimester screening examination
Baschat, A., Magder, L. S., Doyle, L. E., Atlas, R., Jenkins, C., & Blitzer, M. G. (2014) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2014.04.018 · Cited by 90
ACOG Committee Opinion No. 743 Summary: Low-Dose Aspirin Use During Pregnancy
(2018) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000002709 · Cited by 88
Prediction of imminent preeclampsia at 35–37 weeks gestation
Ciobanu, A. M., Wright, A., Panaitescu, A. M., Syngelaki, A., Wright, D. E., & Nicolaides, K. H. (2019) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2019.01.235 · Cited by 72
Self-citationStepan, H., Hund, M., Gencay, M., Denk, B., Dinkel, C., Kaminski, W. E., Wieloch, P., Semus, B., Meloth, T., Dröge, L.-A., et al. (2016) · Hypertension in Pregnancy · doi:10.3109/10641955.2016.1141214 · Cited by 68
Two-stage screening for preterm preeclampsia at 11–13 weeks’ gestation
Wright, A., Wright, D. E., Syngelaki, A., Georgantis, A., & Nicolaides, K. H. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.10.092 · Cited by 64
Self-citationLai, J., Garcia-Tizon Larroca, S., Peeva, G., Poon, L. C., Wright, D., & Nicolaides, K. H. (2014) · Fetal Diagnosis and Therapy · doi:10.1159/000359968 · Cited by 63
Self-citationTsiakkas, A., Duvdevani, N., Wright, A., Wright, D. E., & Nicolaides, K. H. (2015) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.14817 · Cited by 62
Self-citationManagement of pregnancies after combined screening for pre‐eclampsia at 19–24 weeks' gestation
Litwińska, M., Syngelaki, A., Wright, A., Wright, D. E., & Nicolaides, K. H. (2018) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.19099 · Cited by 61
Self-citationO’Gorman, N., Tampakoudis, G., Wright, A., Wright, D., & Nicolaides, K. H. (2015) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.15819 · Cited by 53
Self-citationFrancisco, C., Wright, D., Benkő, Z., Syngelaki, A., & Nicolaides, K. H. (2017) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.17529 · Cited by 47
Self-citationTsiakkas, A., Cazacu, R., Wright, A., Wright, D., & Nicolaides, K. H. (2015) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.15816 · Cited by 46
Self-citationContingent screening for preterm pre-eclampsia
Wright, D., Gallo, D. M., Gil Pugliese, S., Casanova, C., & Nicolaides, K. H. (2016) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.15807 · Cited by 40
Self-citationMean arterial pressure at 12, 22, 32 and 36 weeks' gestation in screening for pre-eclampsia
Tayyar, A. T., Krithinakis, K., Wright, A., Wright, D., & Nicolaides, K. H. (2015) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.15815 · Cited by 40
Self-citationWright, D., Dragan, I., Syngelaki, A., Akolekar, R., & Nicolaides, K. H. (2016) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.17309 · Cited by 36
Self-citationPanaitescu, A. M., Wright, D. E., Militello, A., Akolekar, R., & Nicolaides, K. H. (2017) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.17419 · Cited by 34
Self-citationLitwińska, M., Wright, D. E., Efetürk, T., et al. (2017) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.17418 · Cited by 33
Self-citationDragan, I., Wright, D., Fiolna, M., Leipold, G., & Nicolaides, K. H. (2016) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.17310 · Cited by 32
Self-citationTsiakkas, A., Méndez, O., Wright, A., Wright, D., & Nicolaides, K. H. (2015) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.15817 · Cited by 29
Self-citationBenkő, Z., Chaveeva, P., Matallana, C. D. P., Zingler, E., Wright, A., Wright, D. E., & Nicolaides, K. H. (2019) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.20265 · Cited by 25
Self-citationBenkő, Z., Chaveeva, P., Matallana, C. D. P., Zingler, E., Wright, D. E., & Nicolaides, K. H. (2019) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.20411 · Cited by 19
Self-citation
Cited by
Dimitriadis, E., Rolnik, D. L., Zhou, W., Estrada-Gutierrez, G., Koga, K., Francisco, R. P. V., Whitehead, C., Hyett, J., da Silva Costa, F., Nicolaides, K., et al. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00417-6 · Cited by 866
Self-citationMagee, L. A., Nicolaides, K. H., & von Dadelszen, P. (2022) · New England Journal of Medicine · doi:10.1056/nejmra2109523 · Cited by 546
Self-citationPapastefanou, I., Wright, D., Lolos, M., Anampousi, K., Mamalis, M., & Nicolaides, K. H. (2021) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.23118 · Cited by 40
Self-citationMalone, S. L., Haj Yahya, R., & Kane, S. C. (2022) · International Journal of Women's Health · doi:10.2147/ijwh.s283239 · Cited by 32
“Competing Risk Model Using Multiparametric Screening Tests The competing risk model treats preeclampsia as an event in time.(42) It assumes that were a pregnancy to continue”
BackgroundMethod
Metadata
- Authors
- Wright, D., Wright, A., & Nicolaides, K. H.
- Venue
- American Journal of Obstetrics and Gynecology
- Publisher
- Elsevier BV
- Published
- 2020-07
- Volume
- 223
- Issue
- 1
- Pages
- 12-23.e7
- ISSN
- 0002-9378 (ISSN-L)
- OpenAlex
- W2986009663
- Cited by
- 263
- References
- 63
- FWCI
- 24.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.